NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
---|---|---|---|---|---|---|---|
Revenue YoY % growth | N/A | N/A 358.72% | |||||
EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
EBIT YoY % growth | -6.46M | -4.45M 31.11% | -11.61M -160.90% | -14.21M -22.39% | N/A -25.88% | N/A -19.16% | |
Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 73.04% | N/A 72.26% |
All data in USD
Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
---|---|---|---|---|---|
EPS Q2Q % growth | -0.90 83.66% | -0.63 86.82% | -0.60 42.15% | -0.52 53.17% | -0.43 51.69% |
Revenue Q2Q % growth | 151.5K | 151.5K | 202K | 252.5K 271.32% | 404K 166.67% |
EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
EBIT Q2Q % growth | -4.682M -59.10% | -5.45M -37.97% | -5.386M -15.36% | -5.305M -19.04% | -5.176M -10.55% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2024 Q2Q % growth | -1.10 87.78% | -1.14 | 0.04 | 3.62% |
Q2 2024 Q2Q % growth | -1.03 85.29% | -1.42 | 0.39 | 27.67% |
Q1 2024 Q2Q % growth | -4.75 | -3.79 | -0.96 | -25.41% |
Q4 2023 Q2Q % growth | -5.50 | -3.28 | -2.22 | -67.56% |
Q3 2023 Q2Q % growth | -9.00 | -6.31 | -2.69 | -42.57% |
Q2 2023 Q2Q % growth | -7.00 | -6.31 | -0.69 | -10.89% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q3 2024 Q2Q % growth | 68K | 75.75K | -7.75K | -10.23% |
Q2 2024 Q2Q % growth | 10.1K | -10.1K | -100.00% | |
Q1 2024 Q2Q % growth | 151.5K | -151.5K | -100.00% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | 49.14% | 0% | 3% |
Revenue | 0% | -50% | 0% | -3.11% |